BRAF and cancer: BRAF inhibition promotes cancer cell-autonomous mechanisms of ECM production and pro-fibrotic features in these xenograft models of melanoma therapeutic responses associated with ECM reprogramming, accumulation of collagen fibers and tumor stiffening in TT-treated mice [13] (Fig. 1).